文献速递母胎医学产科

胸腔-羊膜腔分流术治疗严重原发性胎儿胸腔积液的围产儿结局

[Perinatal outcomes of thoraco-amniotic shunting for severe primary fetal hydrothorax].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2018-01-01

回顾性分析22例严重原发性胎儿胸腔积液行胸腔-羊膜腔分流术的病例,共放置分流管28次,中位置管孕周31.3周,活产率95%(21/22),围产儿存活率81%(17/21),术后7天内胎膜早破发生率9%(2/22),分流管移位或堵塞发生率18%(4/22),4例新生儿死亡均归因于肺发育不良。

要点

  • TAS中位置管孕周31.3周,至分娩中位间隔26天,活产率95%(21/22)。
  • 围产儿总存活率81%(17/21),伴水肿者存活10/13,不伴水肿者存活7/8。
  • 术后7天内胎膜早破发生率9%(2/22),分流管移位或堵塞发生率18%(4/22)。

核心结论

  • 胸腔-羊膜腔分流术是相对安全的宫内干预技术,可改善严重原发性胎儿胸腔积液的围产结局。

研究设计与样本

  • 回顾性分析2012年1月至2017年12月同济大学附属第一妇婴保健院胎儿医学科及产前诊断中心收治的22例经胸腔-羊膜腔分流术宫内干预的严重原发性胎儿胸腔积液病例。
  • 排除因胎儿结构或染色体异常、感染及免疫性水肿等所致的继发性胸腔积液胎儿。

主要发现

  • 22例胎儿共放置分流管28次,一次置管成功率为100%,进行TAS的中位孕周为31.3周(第25百分位数~第75百分位数:27.6~32.2周)。
  • TAS后7天内胎膜早破发生率为9%(2/22),分流管移位或堵塞发生率为18%(4/22),TAS至分娩的中位间隔时间为26天(8~46天)。
  • 引产1例(5%,1/22),活产21例(95%,21/22),分娩孕周为34.4周(33.4~37.0周)。
  • 13例(62%,13/21)新生儿出生后需机械通气,4例新生儿死亡,死亡原因均为肺发育不良。
  • 围产儿存活率为81%(17/21),其中胸腔积液伴水肿和不伴水肿围产儿的存活率分别为10/13、7/8。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the safety and perinatal outcomes of thoracoamniotic shunting in the treatment of fetuses with severe primary hydrothorax. Methods: 22 cases of suspected severe primary fetal hydrothorax which underwent thoraco-amniotic shunting in Shanghai First Maternity and Infant Hospital, Fetal Medicine Unit and Prenatal Diagnosis Center from January 2012 to December 2017 were analyzed retrospectively. Hydrothorax associated with structural or chromosomal abnormalities, infections and immune fetal hydrops were excluded. Results: Totally, 28 shunts were placed in 22 fetuses. The median gestational age at TAS was 31.3 weeks. Preterm membrane rupture within 7 days after the procedure occurred in 9.1% (2/22) cases. Catheter displacement occurred in 18% (4/22) cases. The interval from shunting to delivery was 26.0 days. One fetus ended in induced abortion; 21 (95%, 21/22) babies were born alive, and their median gestational age at delivery was 34.4 weeks. 62% (13/21) newborns required ventilator supports; 4 neonatal deaths were attributed to pulmonary hypoplasia. The overall perinatal survival rate was 81% (17/21) . The perinatal survival rate with hydrops and without hydrops were 10/13 and 7/8 respectively. Conclusion: Thoraco-amniotic shunting is a safe procedure for intrauterine therapy and could improve the perinatal outcomes of severe primary fetal hydrothorax. 目的: 评估胸腔-羊膜腔分流术(TAS)在严重原发性胸腔积液(PFHT)胎儿的治疗中应用的安全性及围产儿结局。 方法: 回顾性分析2012年1月至2017年12月在同济大学附属第一妇婴保健院就诊的22例经TAS宫内干预的严重PFHT胎儿的围手术期管理及妊娠结局,排除因胎儿结构或染色体异常、感染及免疫性水肿等所致的继发性胸腔积液胎儿。 结果: 22例经TAS治疗的严重PFHT胎儿中,共放置分流管28次,一次置管成功率为100%,进行TAS的中位孕周为31.3周(第25百分位数~第75百分位数:27.6~32.2周)。TAS后7 d内胎膜早破的发生率为9%(2/22),分流管移位或堵塞的发生率为18%(4/22),TAS至分娩的中位间隔时间为26 d(8~46 d)。引产1例(5%,1/22),活产21例(95%,21/22),分娩孕周为34.4周(33.4~37.0周);13例(62%,13/21)新生儿出生后需机械通气;4例新生儿死亡,死亡原因均为肺发育不良。围产儿的存活率为81%(17/21),其中胸腔积液伴水肿和不伴水肿围产儿的存活率分别为10/13、7/8。 结论: TAS是相对安全的宫内干预技术,可改善严重PFHT胎儿的围产结局。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wei X, Meng M, Zou G, et al. [Perinatal outcomes of thoraco-amniotic shunting for severe primary fetal hydrothorax]. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 30293293. doi:10.3760/cma.j.issn.0529-567x.2018.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。